BRISTOL, Tenn., Feb. 9 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) reported today that the company plans to announce earnings for
the fourth quarter and year ending December 31, 2003, prior to the market open
on Thursday, February 19, 2004. Conference call information will be provided
when available via a subsequent press release.
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated date for release of the
Company's financial results for the fourth quarter and year ending December
31, 2003 and the live webcast of the conference call following the release.
These forward-looking statements involve certain significant risks and
uncertainties, and actual results may differ materially from the forward-
looking statements. Some important factors which may cause results to differ
include: dependence on King's ability to release the Company's financial
results for fourth quarter and year ending December 31, 2003, and conduct its
conference call as currently planned on February 19, 2004. Other important
factors that may cause actual results to differ materially from the forward-
looking statements are discussed in the "Risk Factors" section and other
sections of King's Form 10-K for the year ended December 31, 2002 and Form 10-
Q for the third quarter ended September 30, 2003, which is on file with the
Securities and Exchange Commission. King does not undertake to publicly
update or revise any of its forward-looking statements even if experience or
future changes show that the indicated results or events will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
Company News On-Call:
http://www.prnewswire.com/comp/120319.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs, of King Pharmaceuticals, Inc., +1-423-989-8125
|
